Dazhuo Shi

519 total citations
33 papers, 384 citations indexed

About

Dazhuo Shi is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Surgery. According to data from OpenAlex, Dazhuo Shi has authored 33 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 14 papers in Complementary and alternative medicine and 12 papers in Surgery. Recurrent topics in Dazhuo Shi's work include Traditional Chinese Medicine Analysis (13 papers), Coronary Interventions and Diagnostics (10 papers) and Cardiac Imaging and Diagnostics (9 papers). Dazhuo Shi is often cited by papers focused on Traditional Chinese Medicine Analysis (13 papers), Coronary Interventions and Diagnostics (10 papers) and Cardiac Imaging and Diagnostics (9 papers). Dazhuo Shi collaborates with scholars based in China and United States. Dazhuo Shi's co-authors include Hao Xu, Keji Chen, Ming Guo, Xiaojuan Ma, Xiaoyan Lu, Ying Zhang, Hua Qu, Lin Xu, Shu-zheng Lü and Tianchang Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Ethnopharmacology.

In The Last Decade

Dazhuo Shi

31 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dazhuo Shi China	12	156	135	130	50	44	33	384
Xianliang Wang China	12	130 0.8×	121 0.9×	169 1.3×	21 0.4×	71 1.6×	57	417
Changgeng Fu China	12	85 0.5×	74 0.5×	143 1.1×	28 0.6×	47 1.1×	55	348
Zhong-Qi Yang China	9	73 0.5×	82 0.6×	149 1.1×	21 0.4×	47 1.1×	43	360
Dezhi Zheng China	11	110 0.7×	59 0.4×	138 1.1×	41 0.8×	15 0.3×	33	365
Xinke Zhao China	11	42 0.3×	117 0.9×	84 0.6×	25 0.5×	22 0.5×	34	271
Qiaoning Yang China	10	59 0.4×	50 0.4×	115 0.9×	25 0.5×	31 0.7×	24	277
Shoji Nakai Japan	13	37 0.2×	140 1.0×	70 0.5×	45 0.9×	57 1.3×	30	373
Bingxuan Zhang China	12	36 0.2×	87 0.6×	115 0.9×	29 0.6×	17 0.4×	28	358
Daniele Mendes Guizoni Brazil	15	86 0.6×	256 1.9×	141 1.1×	86 1.7×	8 0.2×	30	521

Countries citing papers authored by Dazhuo Shi

Since Specialization

Citations

This map shows the geographic impact of Dazhuo Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dazhuo Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dazhuo Shi more than expected).

Fields of papers citing papers by Dazhuo Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dazhuo Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dazhuo Shi. The network helps show where Dazhuo Shi may publish in the future.

Co-authorship network of co-authors of Dazhuo Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Dazhuo Shi. A scholar is included among the top collaborators of Dazhuo Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dazhuo Shi. Dazhuo Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Dazhuo, et al.. (2024). Vascular smooth muscle cell phenotypic switching in atherosclerosis. Heliyon. 10(18). e37727–e37727. 19 indexed citations

Yang, Qiaoning, Ming Guo, Z Gao, et al.. (2022). The effectiveness and safety of Chinese Patent Medicines based on syndrome differentiation in patients following percutaneous coronary intervention due to acute coronary syndrome (CPM trial): A nationwide Cohort Study. Phytomedicine. 109. 154554–154554. 11 indexed citations

Qu, Hua, et al.. (2022). Lipid-Lowering Efficacy of the Capsaicin in Patients With Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Nutrition. 9. 812294–812294. 6 indexed citations

Qu, Hua, Ying Zhang, Fan Zhang, et al.. (2021). Efficacy and Safety of Xinyue Capsule for Coronary Artery Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 2 indexed citations

Guo, Ming, Deng Pan, Pengfei Chen, et al.. (2021). Serum Uric Acid and Risk of Chronic Heart Failure: A Systematic Review and Meta-Analysis. Frontiers in Medicine. 8. 785327–785327. 20 indexed citations

Ma, Xiaojuan, Ying Zhang, Jie Gao, et al.. (2021). Combination of Activating Blood Circulation and Detoxifying Chinese Medicines Played an Anti-Inflammatory Role in Unstable Angina Patients after Percutaneous Coronary Intervention: A Multicenter, Open-Labeled, Randomized Controlled Trial. Chinese Journal of Integrative Medicine. 27(11). 803–810. 2 indexed citations

Li, Jingen, Z Gao, Lijing Zhang, et al.. (2019). Qing-Xin-Jie-Yu Granule for patients with stable coronary artery disease (QUEST Trial): A multicenter, double-blinded, randomized trial. Complementary Therapies in Medicine. 47. 102209–102209. 12 indexed citations

Wang, Peili, et al.. (2019). The efficacy of Chinese herbal medicines on acute coronary syndrome with renal insufficiency after percutaneous coronary intervention. Journal of Ethnopharmacology. 248. 112354–112354. 11 indexed citations

Zhang, Jingchun, Yue Liu, Zhiqi Liang, et al.. (2018). Efficacy and Safety of Zhenyuan Capsule for Coronary Heart Disease with Abnormal Glucose and Lipid Metabolism: Study Protocol for a Randomized, Double‐Blind, Parallel‐Controlled, Multicenter Clinical Trial. Evidence-based Complementary and Alternative Medicine. 2018(1). 1716430–1716430. 8 indexed citations

10.

Mao, Huimin, Mi Liu, Hua Qu, Li‐Qiong Wang, & Dazhuo Shi. (2017). Tongxinluo Capsule (通心络胶囊) for Cardiac Syndrome X: A Systematic Review and Meta-Analysis. Chinese Journal of Integrative Medicine. 24(4). 296–303. 7 indexed citations

11.

Guo, Ming, Hua Qu, Lin Xu, & Dazhuo Shi. (2017). Tea consumption may decrease the risk of osteoporosis: an updated meta-analysis of observational studies. Nutrition Research. 42. 1–10. 30 indexed citations

12.

Zhang, Lei, Qiaoning Yang, Zhu-ye Gao, et al.. (2016). Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention: A multicenter randomized controlled trial. Chinese Journal of Integrative Medicine. 23(10). 740–746. 3 indexed citations

13.

Luo, Jing, Anlu Wang, Hao Xu, Dazhuo Shi, & Keji Chen. (2016). Expecting the holistic regulation from Chinese medicine based on the “solar system” hypothesis of ischemic heart disease. Chinese Journal of Integrative Medicine. 22(11). 805–810. 1 indexed citations

14.

Zhang, Ying, Xiaojuan Ma, & Dazhuo Shi. (2015). Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis. PLoS ONE. 10(9). e0137775–e0137775. 26 indexed citations

15.

Wang, Chenglong, Peili Wang, Hao Xu, et al.. (2015). Resting heart rate associates with one-year risk of major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention. Experimental Biology and Medicine. 241(5). 478–484. 18 indexed citations

16.

Xue, Mei, Hui-jun Yin, Caifeng Wu, et al.. (2011). Effect of Chinese drugs for activating blood circulation and detoxifying on indices of thrombosis, inflammatory reaction, and tissue damage in a rabbit model of toxin-heat and blood stasis syndrome. Chinese Journal of Integrative Medicine. 19(1). 42–47. 11 indexed citations

17.

Shang, Qinghua, Hao Xu, Xiaoyan Lu, et al.. (2011). A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule (芎芍胶囊) in preventing restenosis after percutaneous coronary intervention: A subgroup analysis of senile patients. Chinese Journal of Integrative Medicine. 17(9). 669–674. 33 indexed citations

18.

Ma, Xiaojuan, Shang‐Jun Yin, Caifeng Wu, et al.. (2010). Synergistic protection of Danhong Injection (丹红注射液) and ischemic postconditioning on myocardial reperfusion injury in minipigs. Chinese Journal of Integrative Medicine. 16(6). 531–536. 24 indexed citations

19.

Chen, Keji, Dazhuo Shi, Shu-zheng Lü, et al.. (2006). XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China. Chinese Medical Journal. 119(1). 6–13. 54 indexed citations

20.

Xu, Hao, et al.. (2002). Clinical study of xiongshao capsule in preventing restenosis after coronary interventional treatment. Chinese Journal of Integrated Traditional and Western Medicine. 8(3). 162–166. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact